TRML

Tourmaline Bio (TRML)

Tourmaline Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TRML

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	20:10	GlobeNewswire Inc.	Tourmaline Bio to Present at the Jefferies Global Healthcare Conference	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/16	20:00	GlobeNewswire Inc.	Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/14	05:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/13	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/05/13	20:00	GlobeNewswire Inc.	Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:TRML	Tourmaline Bio Inc
2024/04/02	20:00	GlobeNewswire Inc.	Avalo Therapeutics Appoints Biotech Leaders to Board of Directors	NASDAQ:TRML	Tourmaline Bio Inc
2024/03/19	20:00	GlobeNewswire Inc.	Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/27	21:30	GlobeNewswire Inc.	Tourmaline Bio to Present at Upcoming Investor Conferences	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/15	11:08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/15	10:51	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/10	06:22	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:TRML	Tourmaline Bio Inc
2024/02/01	22:00	GlobeNewswire Inc.	Tourmaline Bio to Present at the Guggenheim Healthcare Talks \| 6th Annual Biotechnology Conference	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/30	06:01	GlobeNewswire Inc.	Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/27	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/27	06:08	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	21:00	GlobeNewswire Inc.	Tourmaline Bio Announces Pricing of Public Offering of Common Stock	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	11:20	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	07:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/25	06:05	GlobeNewswire Inc.	Tourmaline Bio Announces Proposed Public Offering of Common Stock	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/08	23:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2024/01/08	21:00	GlobeNewswire Inc.	Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)	NASDAQ:TRML	Tourmaline Bio Inc
2023/12/16	06:00	GlobeNewswire Inc.	Tourmaline Bio added to the NASDAQ Biotechnology Index	NASDAQ:TRML	Tourmaline Bio Inc
2023/12/14	22:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2023/12/14	21:30	GlobeNewswire Inc.	Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board	NASDAQ:TRML	Tourmaline Bio Inc
2023/11/30	22:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TRML	Tourmaline Bio Inc
2023/11/01	21:00	GlobeNewswire Inc.	Tourmaline Bio to Present at Upcoming Investor Conferences	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc
2023/10/24	09:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TRML	Tourmaline Bio Inc